logo
Plus   Neg
Share
Email

UK Same Store Sales Rise In January - BRC

Same store sales in the United Kingdom improved in January.

The British Retail Consortium and KPMG reported Tuesday that on a like-for-like basis, sales were up 1.9 percent compared to January 2012.

BRC said it was the highest like-for-like growth in 13 months.

Total retail sales were up 3.0 percent on year. It marked the highest overall sales growth since September 2012.

BRC said online sales were up 10.1 percent on year.

"After a fairly subdued December, these results are sure to lift spirits for many. Retailers didn't have high hopes for strong sales at Christmas, but this meant that they prepared well and headed into the New Year with less stock to clear than last year," said BRC Director General Helen Dickinson. "People were tempted out by offers and promotions but also treated themselves to full-price and premium products early in January, particularly must-have technology items. These factors, coupled with recovering consumer confidence, have added up to a more successful January than we saw last year."

by RTTNews Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
In the age of social media, it takes mere hours for a company to suffer the backlash of of allegations of racism. For some companies, these incidents have hurt their bottom line and sullied their reputations. For others, they were a blip caused by clumsy if not altogether coincidental missteps. In... BJ's Wholesale Club Holdings Inc., which is planning a return to the public market, has set terms for its planned initial public offering or IPO. In a filing with the U.S. Securities and Exchange Commission, the warehouse club operator said Monday that it plans to offer 37.5 million shares priced between $15 and $17 per share. At the top end of the range, the offering would raise $637.5 million. Shares of Valeant Pharmaceuticals International Inc. are falling more than 6 percent in Monday's trading following news that the U.S. Food and Drug Administration has failed to approve the Canada-based company's Duobrii lotion for the treatment of plaque psoriasis. Ortho Dermatologics, a division of Valeant Pharmaceuticals, said it has received a Complete Response Letter or CRL from the FDA.
Follow RTT